Remediating Access Programmes Following Acquisitions or Organisational Change

• Assessing inherited access programmes against internal standards without interrupting treatment
• Prioritising remediation activities while maintaining non-negotiable patient continuity
• Aligning governance, documentation, and vendors under a new operating model
• Managing internal risk and accountability during programme integration

Speakers:

Corinde Staring

Associate Director Evidence Generation

Genmab